TO ASSESS EFFICACY OF PUNARNAVA MANDURA WITH AND WITHOUT SHATAVARI AVALEHA IN PREGNANCY ANAEMIA

A RANDOMIZED COMPARATIVE CLINICAL STUDY TO ASSESS EFFICACY OF PUNARNAVA MANDURA WITH AND WITHOUT SHATAVARI AVALEHA IN GARBHINI PANDU

Status

Active, not recruiting

Phases

Phase 2Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2019/06/019626

Enrollment

Registered

2019-06-11

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: O00-O9A- Pregnancy, childbirth and the puerperium

Interventions

Intervention1: Punarnava Mandura and Shatavari Avaleha: Punarnava Mandura 500mg 2 times/day 30 min before meals with Butter milk. Shatavari Avaleha 5 gm 2 times/day with milk Duration- 2 months Contr

Eligibility

Inclusion criteria

Inclusion criteria: A Pregnant woman with haemoglobin percentage 7.0-10.00 gm/dl, haematocrit less than 30%. A pregnant woman with anaemia in 13th to 28th week of pregnancy.

Exclusion criteria

Exclusion criteria: Anaemia other than iron deficiency anaemia. Patients having haemoglobin percentage less than 7.0 gm/dl. Patients suffering from systemic diseases like Hypertension, Diabetes, Thyroid disorders, Liver disorders, Renal disorder, Cardio Vascular disorders, Cerebro-Vascular disorders, Tuberculosis etc. Patients suffering from pregnancy related complications such as pregnancy induced hypertension, pre- eclampsia, eclampsia, hyper emesis gravidarum, gestational diabetes etc. Pregnancy associated with Rh Incompatibility, Jaundice, Ovarian tumour, Placenta Previa, Abruptio Placenta.

Design outcomes

Primary

Measure	Time frame
To assess the efficacy of Punarnava Mandura with and without Shatavari Avaleha in the management of Garbhini Pandu with special reference to improvement in haemoglobin percentage. Timepoint: To assess the efficacy of Punarnava Mandura with and without Shatavari Avaleha in the management of Garbhini Pandu with special reference to improvement in haemoglobin percentage.Duration- 2 months	—

Secondary

Measure	Time frame
To assess the efficacy of Punarnava Mandura with and without Shatavari Avaleha in the management of Garbhini Pandu with special reference to improvement in haemoglobin percentage. Timepoint: To improve haemoglobin percentage in pregnant women. To reduce consequences of preterm lobour and intra uterine growth retardation. To reduce complications during labour.	—

Countries

India

Contacts

Public ContactMoushami Kulhare

National Institute of Ayurveda Jaipur

baruhunt@gmail.com9982678508

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026